STRATEGIC COMMUNICATIONS
Credibility
that converts
Your device's clinical evidence is only as powerful as your ability to communicate it. Empire HealthTech produces evidence-based content that builds trust with clinicians, investors, procurement teams, and the market β without sacrificing scientific rigor.
3β4 wk
WHITEPAPER TURNAROUND
$8K+
WHITEPAPER ENTRY POINT
Dual
SCIENTIFIC & COMMERCIAL LENS
Claims
REGULATORY-REVIEWED COPY
Most health technology companies have strong science and weak storytelling. We close that gap. Every piece of content we produce is grounded in clinical evidence, aligned with your regulatory position, and written to move the specific audience you need to reach.
WHO WE WRITE FOR
Every audience your device needs to win over
WHAT'S INCLUDED
Strategic health communications
Every deliverable is evidence-based, claims-reviewed, and written by specialists who understand both the science and the commercial context of health technology.
Authoritative, evidence-based whitepapers that position your device's clinical evidence for clinician, investor, and procurement audiences β delivered in 3β4 weeks.
Clinically accurate, commercially compelling website copy β written for device and health technology companies that need to communicate complex science clearly and credibly.
Narrative development and content for investor decks, board presentations, and funding materials that communicate your clinical differentiation with confidence.
Articles, opinion pieces, conference abstracts, and KOL content that builds your organisation's profile in medtech, digital health, and health innovation circles.
OUR STANDARD
What separates
clinical content
from marketing copy
Health technology content fails when it reads like marketing. It succeeds when it reads like science β with a commercial point of view. Every deliverable we produce is held to both standards simultaneously.
01
Evidence-first, always
Every claim is grounded in published literature, clinical data, or your own study outcomes β never assertion without support.
02
Regulatory claims alignment
Copy is reviewed against your device's intended purpose and cleared indications β protecting you from promotional claims that could trigger scrutiny.
03
Audience-specific framing
A clinician reads differently to an investor. We write the same evidence differently for each audience without distorting the science.
04
Consistent with your regulatory story
Communications are aligned with your technical file and CER β so your clinical narrative is never in conflict with your regulatory position.
HOW WE WORK
From brief to publication-ready
We define the audience, the objective, the evidence base, and the key message hierarchy before a word is written.
We audit available clinical data, literature, and your regulatory position to establish what can be said and how.
First draft delivered with structured review cycles β we incorporate your scientific and commercial feedback at every stage.
Publication-ready content with all source references, a claims log, and optional design-ready formatting.
Your science deserves
to be heard clearly.
Whether you need a whitepaper in four weeks or a full communications strategy for a product launch β we scope every engagement around what you actually need.